| Literature DB >> 17931721 |
Anho Liem1, Anton P van de Woestijne, Erik Bruijns, Henk W O Roeters van Lennep, Job A J de Boo, Henk K van Halteren, Teun P van Es, J Wouter Jukema, Arnoud van der Laarse, Aeilko H Zwinderman, Dirk J van Veldhuisen.
Abstract
A pilot study was performed to determine the effect of 40,000 IU Epo on myocardial damage in 51 patients with non-ST segment elevation acute coronary syndrome (non-STE ACS). No significant difference in myocardial damage was found, but an increased systolic blood pressure was noticed.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17931721 DOI： 10.1016/j.ijcard.2007.07.076
Source DB: PubMed Journal: Int J Cardiol ISSN： 0167-5273 Impact factor: 4.164